Zhongzhi Pharmaceutical Holdings (HKSE:03737) Price-to-Tangible-Book : 0.80 (As of Jun. 03, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Zhongzhi Pharmaceutical Holdings Price-to-Tangible-Book?

As of today (2024-06-03), Zhongzhi Pharmaceutical Holdings's share price is HK$1.04. Zhongzhi Pharmaceutical Holdings's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was HK$1.31. Hence, Zhongzhi Pharmaceutical Holdings's Price to Tangible Book Ratio of today is 0.80.

The historical rank and industry rank for Zhongzhi Pharmaceutical Holdings's Price-to-Tangible-Book or its related term are showing as below:

HKSE:03737' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.76 Med: 1.54 Max: 2.52
Current: 0.79

During the past 10 years, Zhongzhi Pharmaceutical Holdings's highest Price to Tangible Book Ratio was 2.52. The lowest was 0.76. And the median was 1.54.

HKSE:03737's Price-to-Tangible-Book is ranked better than
89.86% of 858 companies
in the Drug Manufacturers industry
Industry Median: 2.33 vs HKSE:03737: 0.79

A closely related ratio is called PB Ratio. As of today, Zhongzhi Pharmaceutical Holdings's share price is HK$1.04. Zhongzhi Pharmaceutical Holdings's Book Value per Sharefor the quarter that ended in Dec. 2023 was HK$1.33. Hence, Zhongzhi Pharmaceutical Holdings's P/B Ratio of today is 0.78.

Zhongzhi Pharmaceutical Holdings Price-to-Tangible-Book Historical Data

The historical data trend for Zhongzhi Pharmaceutical Holdings's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhongzhi Pharmaceutical Holdings Price-to-Tangible-Book Chart

Zhongzhi Pharmaceutical Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

1.35

1.54

0.82

0.85

1.09

Zhongzhi Pharmaceutical Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial															0.82	0.75	0.85	0.83	1.09

Competitive Comparison of Zhongzhi Pharmaceutical Holdings's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Zhongzhi Pharmaceutical Holdings's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zhongzhi Pharmaceutical Holdings's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhongzhi Pharmaceutical Holdings's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Zhongzhi Pharmaceutical Holdings's Price-to-Tangible-Book falls into.

Zhongzhi Pharmaceutical Holdings Price-to-Tangible-Book Calculation

Zhongzhi Pharmaceutical Holdings's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	1.04	/	1.308
	=	0.80

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Zhongzhi Pharmaceutical Holdings Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Zhongzhi Pharmaceutical Holdings's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhongzhi Pharmaceutical Holdings (HKSE:03737) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhongzhi Pharmaceutical Holdings Ltd (HKSE:03737) » Definitions » Price-to-Tangible-Book

Traded in Other Exchanges

N/A

Address

No. 3 Kangtai Road South, Torch Development Zone, Guangdong Province, Zhongshan, CHN

Website

https://www.zeus.cn

Zhongzhi Pharmaceutical Holdings Ltd is engaged in the business of manufacturing and selling pharmaceutical products. The group's operations can be divided into three segments, namely Pharmaceutical manufacturing, Operation of chain pharmacies, and Operation of online pharmacies in Zhongshan in the Guangdong province, the PRC. In the Pharmaceutical manufacturing segment, the company is engaged in the research and development, manufacturing and sale of Chinese patent medicines. In the Operation of chain pharmacies segment, the firm operates chain pharmacies in Zhongshan under the brand Zeus for the sale of pharmaceutical products. The Operation of online pharmacies segment sells medicines online. It derives a majority of its revenue from the PRC.

Executives

Jiang Li Xia	2202 Interest of your spouse
Lai Zhi Tian	2201 Interest of corporation controlled by you
Crystal Talent Investment Group Limited	2101 Beneficial owner
Cheng Jin Le	2201 Interest of corporation controlled by you
Advance Keypath Global Investment Limited	2101 Beneficial owner
Novich Positioning Investment (cayman) Limited	2201 Interest of corporation controlled by you
Novich Positioning Investment Limited Partnership	2101 Beneficial owner

Zhongzhi Pharmaceutical Holdings (HKSE:03737) Headlines

No Headlines